The protective M proteins of the equine group C streptococci.

This research article explores the role of M proteins in protecting horses from group C streptococci, a common bacterium that causes illness. While the bacteria’s hyaluronic acid capsule isn’t linked to immune protection, the M protein triggers potent immune responses that may help protect horses. However, current vaccines based on M protein extracts are not highly effective, and the exact protective mechanisms are still unclear.

M Protein and Role in Horse Health

• The study focuses on two strains of Group C streptococci, S. equi and S. zooepidemicus, which are prevalent in horses and often result in disease.
• The bacterium’s vital virulence, or the disease-producing ability, factors include a hyaluronic acid capsule and the M protein.
• The M protein is classified as a ‘superantigen,’ a class of antigens that can incite an exceptionally strong immune response from both B and T cells. This response could potentially result in immune protection against the bacteria.

Understanding Hyaluronic Acid Capsule and Immunity

• The bacteria are covered with a hyaluronic acid capsule that is non-antigenic, meaning it doesn’t elicit an immune response and, as such, doesn’t contribute to immune protection.
• However, the M protein – which is situated on the cell wall surface and extends within and through the hyaluronic acid capsule – elicits an immune response that may provide protection.

Limited Efficiency of M Protein-based Vaccines

• Despite the usual response to M protein, vaccines that are based on extracted M protein do not provide highly successful protection when exposed to real-world conditions.
• It can be challenging to distinguish between antibodies that provide protection (opsonic or mucosal antibodies) and other antibodies generated against the varied epitopes on the M molecule.

Test Models

• Bactericidal tests, which ascertain opsonization for equine neutrophils, can partially assay protective antibodies to S. equi or S. zooepidemicus.
• A mouse-challenge model has been deployed to test the immunizing efficacy of streptococcal extracts and measure protective antibody levels during a passive protection test.

Future Directions

• There remains a need for further research to fully understand how the M proteins can be utilized or improved upon in vaccine development to enhance protection against Group C streptococci infections in horses.